Works matching AU Ho, Alan L

Results: 22

Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. 830, doi. 10.1210/clinem/dgae512
By:
- Konda, Bhavana;
- Sherman, Eric J;
- Massarelli, Erminia;
- Nieva, Jorge;
- Muzaffar, Jameel;
- Morris, John C;
- Ryder, Mabel;
- Ho, Alan L;
- Agulnik, Mark;
- Wei, Lai;
- Handley, Demond;
- Moses, Catherine;
- Jacob, Rajani;
- Wright, John;
- Streicher, Howard;
- Carson, William;
- Shah, Manisha H
Publication type:
Article
Therapeutic strategies for systemic therapies of human papillomavirus‐related oropharyngeal cancer.
Published in:
Journal of Surgical Oncology, 2021, v. 124, n. 6, p. 952, doi. 10.1002/jso.26688
By:
- Hung, Tony K. W.;
- Ho, Alan L.;
- Pfister, David G.
Publication type:
Article
The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.
Published in:
Cell Cycle, 2012, v. 11, n. 4, p. 807, doi. 10.4161/cc.11.4.19323
By:
- Nair, Jayasree S.;
- Ho, Alan L.;
- Schwartz, Gary K.
Publication type:
Article
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Published in:
JAMA Network Open, 2022, v. 5, n. 11, p. e2241538, doi. 10.1001/jamanetworkopen.2022.41538
By:
- Youssef, Irini;
- Yoon, Jennifer;
- Mohamed, Nader;
- Zakeri, Kaveh;
- Press, Robert H.;
- Chen, Linda;
- Gelblum, Daphna Y.;
- McBride, Sean M.;
- Tsai, Chiaojung Jillian;
- Riaz, Nadeem;
- Yu, Yao;
- Cohen, Marc A.;
- Dunn, Lara Ann;
- Ho, Alan L.;
- Wong, Richard J.;
- Michel, Loren S.;
- Boyle, Jay O.;
- Singh, Bhuvanesh;
- Kriplani, Anuja;
- Ganly, Ian
Publication type:
Article
The evolving landscape of salivary gland tumors.
Published in:
CA: A Cancer Journal for Clinicians, 2023, v. 73, n. 6, p. 597, doi. 10.3322/caac.21807
By:
- Steuer, Conor E.;
- Hanna, Glenn J.;
- Viswanathan, Kartik;
- Bates, James E.;
- Kaka, Azeem S.;
- Schmitt, Nicole C.;
- Ho, Alan L.;
- Saba, Nabil F.
Publication type:
Article
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer.
Published in:
CA: A Cancer Journal for Clinicians, 2023, v. 73, n. 2, p. 164, doi. 10.3322/caac.21758
By:
- Kang, Jung Julie;
- Yu, Yao;
- Chen, Linda;
- Zakeri, Kaveh;
- Gelblum, Daphna Yael;
- McBride, Sean Matthew;
- Riaz, Nadeem;
- Tsai, C. Jillian;
- Kriplani, Anuja;
- Hung, Tony K. W.;
- Fetten, James V.;
- Dunn, Lara A.;
- Ho, Alan L.;
- Boyle, Jay O.;
- Ganly, Ian S.;
- Singh, Bhuvanesh;
- Sherman, Eric J.;
- Pfister, David G.;
- Wong, Richard J.;
- Lee, Nancy Y.
Publication type:
Article
Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical Trials.
Published in:
Journal of Medical Internet Research, 2024, v. 26, p. 1, doi. 10.2196/60695
By:
- Hung, Tony K W;
- Kuperman, Gilad J;
- Sherman, Eric J;
- Ho, Alan L;
- Weng, Chunhua;
- Pfister, David G;
- Mao, Jun J
Publication type:
Article
Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy.
Published in:
Journal of Skin Cancer, 2014, p. 1, doi. 10.1155/2014/284582
By:
- Samstein, Robert M.;
- Ho, Alan L.;
- Lee, Nancy Y.;
- Barker, Christopher A.
Publication type:
Article
Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An 18F-FDG PET Study.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 5, p. 662, doi. 10.2967/jnumed.114.150607
By:
- Nagarajah, James;
- Ho, Alan L.;
- Tuttle, R. Michael;
- Weber, Wolfgang A.;
- Grewal, Ravinder K.
Publication type:
Article
Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.
Published in:
Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01178-z
By:
- Dalin, Martin G.;
- Katabi, Nora;
- Persson, Marta;
- Ken-Wing Lee;
- Makarov, Vladimir;
- Desrichard, Alexis;
- Walsh, Logan A.;
- West, Lyndsay;
- Nadeem, Zaineb;
- Ramaswami, Deepa;
- Havel, Jonathan J.;
- Fengshen Kuo;
- Chadalavada, Kalyani;
- Nanjangud, Gouri J.;
- Ganly, Ian;
- Riaz, Nadeem;
- Ho, Alan L.;
- Antonescu, Cristina R.;
- Ghossein, Ronald;
- Stenman, Göran
Publication type:
Article
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
Published in:
2020
By:
- Hanna, Glenn J.;
- Guenette, Jeffrey P.;
- Chau, Nicole G.;
- Sayehli, Cyrus M.;
- Wilhelm, Christian;
- Metcalf, Robert;
- Wong, Deborah J.;
- Brose, Marcia;
- Razaq, Mohammad;
- Pérez‐Ruiz, Elisabeth;
- Cohen, Ezra E. W.;
- Aggarwal, Rahul;
- Scholz, Catherine;
- Gualberto, Antonio;
- Ho, Alan L.;
- Pérez-Ruiz, Elisabeth
Publication type:
journal article
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.
Published in:
2019
By:
- Sherman, Eric J.;
- Dunn, Lara A.;
- Schöder, Heiko;
- Ho, Alan L.;
- Baxi, Shrujal S.;
- Ghossein, Ronald A.;
- Haque, Sofia S.;
- Sima, Cami;
- Tuttle, Robert Michael;
- Pfister, David G.
Publication type:
journal article
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
Published in:
2017
By:
- Sherman, Eric J.;
- Dunn, Lara A.;
- Ho, Alan L.;
- Baxi, Shrujal S.;
- Ghossein, Ronald A.;
- Fury, Matthew G.;
- Haque, Sofia;
- Sima, Cami S.;
- Cullen, Grace;
- Fagin, James A.;
- Pfister, David G.
Publication type:
journal article
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.
Published in:
Cancer (0008543X), 2013, v. 119, n. 10, p. 1823, doi. 10.1002/cncr.27986
By:
- Fury, Matthew G.;
- Sherman, Eric;
- Ho, Alan L.;
- Xiao, Han;
- Tsai, Frank;
- Nwankwo, Oby;
- Sima, Camelia;
- Heguy, Adrian;
- Katabi, Nora;
- Haque, Sofia;
- Pfister, David G.
Publication type:
Article
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
Published in:
Thyroid, 2022, v. 32, n. 3, p. 273, doi. 10.1089/thy.2021.0565
By:
- Tchekmedyian, Vatche;
- Dunn, Lara;
- Sherman, Eric;
- Baxi, Shrujal S.;
- Grewal, Ravinder K.;
- Larson, Steven M.;
- Pentlow, Keith S.;
- Haque, Sofia;
- Tuttle, R. Michael;
- Sabra, Mona M.;
- Fish, Stephanie;
- Boucai, Laura;
- Walters, Jamie;
- Ghossein, Ronald A.;
- Seshan, Venkatraman E.;
- Knauf, Jeffrey A.;
- Pfister, David G.;
- Fagin, James A.;
- Ho, Alan L.
Publication type:
Article
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.
Published in:
2016
By:
- Nagarajah, James;
- Mina Le;
- Knauf, Jeffrey A.;
- Ferrandino, Giuseppe;
- Montero-Conde, Cristina;
- Pillarsetty, Nagavarakishore;
- Bolaender, Alexander;
- Irwin, Christopher;
- Krishnamoorthy, Gnana Prakasam;
- Saqcena, Mahesh;
- Larson, Steven M.;
- Ho, Alan L.;
- Seshan, Venkatraman;
- Nobuya Ishii;
- Carrasco, Nancy;
- Rosen, Neal;
- Weber, Wolfgang A.;
- Fagin, James A.;
- Le, Mina;
- Ishii, Nobuya
Publication type:
journal article
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Published in:
Oncologist, 2024, v. 29, n. 6, p. e779, doi. 10.1093/oncolo/oyac080
By:
- Le, Xiuning;
- Baik, Christina;
- Bauman, Jessica;
- Gilbert, Jill;
- Brose, Marcia S;
- Grilley-Olson, Juneko E;
- Patil, Tejas;
- McDermott, Ray;
- Raez, Luis E;
- Johnson, Jennifer M;
- Shen, Lin;
- Tahara, Makoto;
- Ho, Alan L;
- Norenberg, Ricarda;
- Dima, Laura;
- Brega, Nicoletta;
- Drilon, Alexander;
- Hong, David S
Publication type:
Article
Androgen Receptor Signaling in Salivary Gland Cancer.
Published in:
Cancers, 2017, v. 9, n. 2, p. 17, doi. 10.3390/cancers9020017
By:
- Watson, Philip A.;
- Dalin, Martin G.;
- Morris, Luc G. T.;
- Ho, Alan L.
Publication type:
Article
A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Published in:
Cancer (0008543X), 2024, v. 130, n. 5, p. 702, doi. 10.1002/cncr.35103
By:
- Ho, Alan L.;
- Foster, Nathan R.;
- Deraje Vasudeva, Shyamprasad;
- Katabi, Nora;
- Antonescu, Cristina R.;
- Frenette, Gary P.;
- Pfister, David G.;
- Erlichman, Charles;
- Schwartz, Gary K.
Publication type:
Article
[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
Published in:
2024
By:
- Backhaus, Philipp;
- Pentlow, Keith S.;
- Ho, Alan L;
- Mauguen, Audrey;
- Fagin, James A;
- Pillarsetty, Naga Vara Kishore;
- Lyashchenko, Serge K.;
- Burnazi, Eva;
- Ghossein, Ronald A.;
- Chhabra, Shalini;
- Abusamra, Murad;
- Larson, Steven M.;
- Schöder, Heiko;
- O'Donoghue, Joseph;
- Weber, Wolfgang;
- Grewal, Ravinder K.
Publication type:
Case Study
Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.
Published in:
PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040439
By:
- Ho, Alan L.;
- Musi, Elgilda;
- Ambrosini, Grazia;
- Nair, Jayasree S.;
- Vasudeva, Shyamprasad Deraje;
- de Stanchina, Elisa;
- Schwartz, Gary K.
Publication type:
Article
Moving toward a better understanding of radioiodine action.
Published in:
Endocrine (1355008X), 2013, v. 44, n. 3, p. 553, doi. 10.1007/s12020-013-0024-x
By:
- Ho, Alan L.
Publication type:
Article

Works matching AU Ho, Alan L

Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.

Therapeutic strategies for systemic therapies of human papillomavirus‐related oropharyngeal cancer.

The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

The evolving landscape of salivary gland tumors.

Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer.

Performance of Retrieval-Augmented Large Language Models to Recommend Head and Neck Cancer Clinical Trials.

Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy.

Correlation of BRAF<sup>V600E</sup> Mutation and Glucose Metabolism in Thyroid Cancer Patients: An <sup>18</sup>F-FDG PET Study.

Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.

A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.

Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.

Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.

Androgen Receptor Signaling in Salivary Gland Cancer.

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).

[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.

Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype.

Moving toward a better understanding of radioiodine action.